Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Does early treatment improve outcomes in N-methyl-D-aspartate receptor encephalitis?

Susan Byrne1, Blathanid McCoy, Bryan Lynch

  • 1Children's University Hospital, Dublin, Ireland; Our Lady's Children's Hospital, Dublin, Ireland.

Developmental Medicine and Child Neurology
|March 20, 2014
PubMed

Insights

Early immunosuppressive therapy for N-methyl-d-aspartate (NMDA) receptor encephalitis in children may improve outcomes. Four of five pediatric patients recovered to baseline after prompt treatment for autoimmune encephalitis.

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • N-methyl-d-aspartate (NMDA) receptor encephalitis is a treatable autoimmune neurological disorder.
  • The impact of early immunosuppressive therapy on the natural history of pediatric NMDA receptor encephalitis remains unclear.

Observation:

  • This study examined five children diagnosed with autoimmune encephalitis, presenting with neuropsychiatric, movement, seizure, and dysautonomic features.
  • All children received empirical immunosuppressive therapy.
  • The median time from symptom onset to treatment was 5 days, with a median follow-up of 24 months.

Findings:

  • Four out of five (80%) children recovered to their baseline neurological function.
  • Early initiation of immunosuppressive therapy was associated with positive clinical outcomes in this cohort.

Implications:

  • Prompt immunosuppressive treatment may significantly improve the recovery trajectory for children with NMDA receptor encephalitis.
  • Further research is warranted to confirm these findings in larger pediatric populations.
  • Understanding the long-term effects of early intervention is crucial for optimizing treatment strategies.

More Related Videos

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

9.5K
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

15.6K

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
175
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K